Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.
Prif Awduron: | Karavitaki, N, Wass, J |
---|---|
Fformat: | Conference item |
Cyhoeddwyd: |
2010
|
Eitemau Tebyg
-
Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
gan: Karavitaki, N, et al.
Cyhoeddwyd: (2013) -
Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
gan: Karavitaki, N, et al.
Cyhoeddwyd: (2013) -
A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology
gan: Emilia Sbardella, et al.
Cyhoeddwyd: (2016-10-01) -
Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
gan: Youngki Lee, et al.
Cyhoeddwyd: (2014-09-01) -
Cabergoline therapy for Macroprolactinoma during pregnancy: A case report
gan: Shahzad Hira, et al.
Cyhoeddwyd: (2012-10-01)